Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

Noradrenergic Modulation on Dopaminergic Neurons

  • REVIEW
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

It is now well accepted that there is a close relationship between noradrenergic and dopaminergic neurons in the brain, especially referring to the modulation of the locus coeruleus–norepinephrine (LC-NE) system on dopamine transmission. The disturbance of this modulation may contribute to neurodegeneration of dopaminergic neurons in Parkinson’s disease. In this article, we briefly review evidence related to such modulation. Firstly, we illustrated the noradrenergic innervation and functional implication for the LC-NE system and nigra–striatum dopaminergic system. Furthermore, we depicted neuroprotective effects of the LC-NE on dopaminergic neurons in vivo and in vitro. Moreover, we present data implicating the potential mechanisms underlying the modulation of the LC-NE system on dopaminergic neurons, in particular the effects of NE as a neurotrophic factor and through its ability to stimulate the expression of other neurotrophic factors, such as the brain-derived neurotrophic factor. Finally, we discussed other mechanisms intrinsic to NE’s effects. A better understanding of the noradrenergic modulation on dopaminergic neurons may be rewarding by significant advances in etiologic study and promising treatment of Parkinson’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

ARs:

Adrenergic receptors

BDNF:

Brain-derived neurotrophic factor

DA:

Dopamine

CREB:

cAMP response element binding

DBH:

Dopamine β-hydroxylase

DSP4:

N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride

LC:

Locus coeruleus

NE:

Norepinephrine

NET:

NE transporter

PD:

Parkinson’s disease

SNpc:

Substantia nigra pars compacta

TrkB:

Tropomyosin receptor kinase B

VTA:

Ventral tegmental area

References

  • Alonso-Vanegas MA, Fawcett JP, Causing CG, Miller FD, Sadikot AF (1999) Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse. J Comp Neurol 413:449–462

    Article  CAS  PubMed  Google Scholar 

  • Aloyz R, Fawcett JP, Kaplan DR, Murphy RA, Miller FD (1999) Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. Learn Mem 6:216–231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Alvarez-Diduk R, Galano A (2015) Adrenaline and noradrenaline: protectors against oxidative stress or molecular targets? J Phys Chem B 119:3479–3491

    Article  CAS  PubMed  Google Scholar 

  • Ancerewicz J, Migliavacca E, Carrupt PA et al (1998) Structure-property relationships of trimetazidine derivatives and model compounds as potential antioxidants. Free Radic Biol Med 25:113–120

    Article  CAS  PubMed  Google Scholar 

  • Anden NE, Hfuxe K, Hamberger B, Hokfelt T (1966) A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. Acta Physiol Scand 67:306–312

    Article  CAS  PubMed  Google Scholar 

  • Anderson CF, Mosser DM (2002) A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 72:101–106

    CAS  PubMed  Google Scholar 

  • Andorn AC, Pappolla MA (2001) Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer’s disease brain. Free Radic Biol Med 31:315–320

    Article  CAS  PubMed  Google Scholar 

  • Antelman SM, Caggiula AR (1977) Norepinephrine-dopamine interactions and behavior. Science 195:646–653

    Article  CAS  PubMed  Google Scholar 

  • Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549–553

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baydyuk M, Xu B (2014) BDNF signaling and survival of striatal neurons. Front Cell Neurosci 8:254

    Article  PubMed  PubMed Central  Google Scholar 

  • Berghuis P, Agerman K, Dobszay MB, Minichiello L, Harkany T, Ernfors P (2006) Brain-derived neurotrophic factor selectively regulates dendritogenesis of parvalbumin-containing interneurons in the main olfactory bulb through the PLCgamma pathway. J Neurobiol 66:1437–1451

    Article  CAS  PubMed  Google Scholar 

  • Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33–84

    Article  PubMed  Google Scholar 

  • Berridge CW, Stratford TL, Foote SL, Kelley AE (1997) Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27:230–241

    Article  CAS  PubMed  Google Scholar 

  • Bing G, Zhang Y, Watanabe Y, McEwen BS, Stone EA (1994) Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res 668:261–265

    Article  CAS  PubMed  Google Scholar 

  • Bjorklund A, Dunnett SB (2007) Dopamine neuron systems in the brain: an update. Trends Neurosci 30:194–202

    Article  PubMed  CAS  Google Scholar 

  • Blin J, Bonnet AM, Agid Y (1988) Does levodopa aggravate Parkinson’s disease? Neurology 38:1410–1416

    Article  CAS  PubMed  Google Scholar 

  • Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358–1362

    Article  CAS  PubMed  Google Scholar 

  • Brodal A (1981) Neurological anatomy in relation to clinical medicine. Oxford University Press, New York, pp 416–419

    Google Scholar 

  • Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68:815–834

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297–305

    Article  CAS  PubMed  Google Scholar 

  • Buettner GR (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300:535–543

    Article  CAS  PubMed  Google Scholar 

  • Cabelli RJ, Hohn A, Shatz CJ (1995) Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF. Science 267:1662–1666

    Article  CAS  PubMed  Google Scholar 

  • Calabresi P, Giacomini P, Centonze D, Bernardi G (2000) Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity? Ann Neurol 47:S60–S68 discussion S68-69

    CAS  PubMed  Google Scholar 

  • Castren E, Thoenen H, Lindholm D (1995) Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience 64:71–80

    Article  CAS  PubMed  Google Scholar 

  • Chen NH, Reith ME (1994) Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats. J Pharmacol Exp Ther 271:1597–1610

    CAS  PubMed  Google Scholar 

  • Chen MJ, Russo-Neustadt AA (2005) Exercise activates the phosphatidylinositol 3-kinase pathway. Brain Res Mol Brain Res 135:181–193

    Article  CAS  PubMed  Google Scholar 

  • Chen MJ, Russo-Neustadt AA (2007) Nitric oxide signaling participates in norepinephrine-induced activity of neuronal intracellular survival pathways. Life Sci 81:1280–1290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen MJ, Nguyen TV, Pike CJ, Russo-Neustadt AA (2007) Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons. Cell Signal 19:114–128

    Article  CAS  PubMed  Google Scholar 

  • Cohen Z, Molinatti G, Hamel E (1997) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 17:894–904

    Article  CAS  PubMed  Google Scholar 

  • Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295–2313

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coradazzi M, Gulino R, Fieramosca F, Falzacappa LV, Riggi M, Leanza G (2016) Selective noradrenaline depletion impairs working memory and hippocampal neurogenesis. Neurobiol Aging 48:93–102

    Article  CAS  PubMed  Google Scholar 

  • Cottingham C, Jones A, Wang Q (2012) Desipramine selectively potentiates norepinephrine-elicited ERK1/2 activation through the alpha2A adrenergic receptor. Biochem Biophys Res Commun 420:161–165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Counts SE, Mufson EJ (2010) Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 113:649–660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Culmsee C, Semkova I, Krieglstein J (1999) NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int 35:47–57

    Article  CAS  PubMed  Google Scholar 

  • da Penha Berzaghi M, Cooper J, Castren E, Zafra F, Sofroniew M, Thoenen H, Lindholm D (1993) Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J Neurosci 13:3818–3826

    Article  PubMed  PubMed Central  Google Scholar 

  • Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905–2927

    Article  CAS  PubMed  Google Scholar 

  • Day JS, O’Neill E, Cawley C, Aretz NK, Kilroy D, Gibney SM, Harkin A, Connor TJ (2014) Noradrenaline acting on astrocytic beta(2)-adrenoceptors induces neurite outgrowth in primary cortical neurons. Neuropharmacology 77:234–248

    Article  CAS  PubMed  Google Scholar 

  • Delaville C, Deurwaerdere PD, Benazzouz A (2011) Noradrenaline and Parkinson’s disease. Front Syst Neurosci 5:31

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL (2004) Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation 1:9

    Article  CAS  Google Scholar 

  • Dobolyi A, Vincze C, Pal G, Lovas G (2012) The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci 13:8219–8258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Domesick VB (1988) Neuroanatomical organization of dopamine neurons in the ventral tegmental area. Ann N Y Acad Sci 537:10–26

    Article  CAS  PubMed  Google Scholar 

  • Edeline JM, Manunta Y, Hennevin E (2011) Induction of selective plasticity in the frequency tuning of auditory cortex and auditory thalamus neurons by locus coeruleus stimulation. Hear Res 274:75–84

    Article  PubMed  Google Scholar 

  • Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311–7316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Elenkov IJ, Hasko G, Kovacs KJ, Vizi ES (1995) Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J Neuroimmunol 61:123–131

    Article  CAS  PubMed  Google Scholar 

  • Encinas M, Iglesias M, Llecha N, Comella JX (1999) Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73:1409–1421

    Article  CAS  PubMed  Google Scholar 

  • Espay AJ, LeWitt PA, Kaufmann H (2014) Norepinephrine deficiency in Parkinson’s disease: the case for noradrenergic enhancement. Mov Disord 29:1710–1719

    Article  CAS  PubMed  Google Scholar 

  • Fawcett JP, Bamji SX, Causing CG, Aloyz R, Ase AR, Reader TA, McLean JH, Miller FD (1998) Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci 18:2808–2821

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283–2301

    Article  PubMed  Google Scholar 

  • Feinstein DL (1998) Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activity. J Neurochem 70:1484–1496

    Article  CAS  PubMed  Google Scholar 

  • Feinstein DL, Galea E, Reis DJ (1993) Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J Neurochem 60:1945–1948

    Article  CAS  PubMed  Google Scholar 

  • Felten DL, Hallman H, Jonsson G (1982) Evidence for a neurotropic role of noradrenaline neurons in the postnatal development of rat cerebral cortex. J Neurocytol 11:119–135

    Article  CAS  PubMed  Google Scholar 

  • Fornai F, Bassi L, Torracca MT, Scalori V, Corsini GU (1995) Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. Eur J Pharmacol 283:99–102

    Article  CAS  PubMed  Google Scholar 

  • Fornai F, Torracca MT, Bassi L, D’Errigo DA, Scalori V, Corsini GU (1996) Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats. Brain Res 735:349–353

    Article  CAS  PubMed  Google Scholar 

  • Fornai F, Alessandri MG, Torracca MT, Bassi L, Scalori V, Corsini GU (1998) Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion. Ann N Y Acad Sci 844:166–177

    Article  CAS  PubMed  Google Scholar 

  • Fukuchi M, Fujii H, Takachi H, Ichinose H, Kuwana Y, Tabuchi A, Tsuda M (2010) Activation of tyrosine hydroxylase (TH) gene transcription induced by brain-derived neurotrophic factor (BDNF) and its selective inhibition through Ca(2+) signals evoked via the N-methyl-D-aspartate (NMDA) receptor. Brain Res 1366:18–26

    Article  CAS  PubMed  Google Scholar 

  • Fulceri F, Biagioni F, Lenzi P, Falleni A, Gesi M, Ruggieri S, Fornai F (2006) Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures. Ann N Y Acad Sci 1074:344–348

    Article  CAS  PubMed  Google Scholar 

  • Fulceri F, Biagioni F, Ferrucci M, Lazzeri G, Bartalucci A, Galli V, Ruggieri S, Paparelli A, Fornai F (2007) Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons. Brain Res 1135:219–229

    Article  CAS  PubMed  Google Scholar 

  • Gesi M, Soldani P, Giorgi FS, Santinami A, Bonaccorsi I, Fornai F (2000) The role of the locus coeruleus in the development of Parkinson’s disease. Neurosci Biobehav Rev 24:655–668

    Article  CAS  PubMed  Google Scholar 

  • Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618–1623

    Article  CAS  PubMed  Google Scholar 

  • Gleeson LC, Ryan KJ, Griffin EW, Connor TJ, Harkin A (2010) The beta2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain Behav Immun 24:1354–1361

    Article  CAS  PubMed  Google Scholar 

  • Gorski JA, Zeiler SR, Tamowski S, Jones KR (2003) Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23:6856–6865

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gozdz A, Habas A, Jaworski J, Zielinska M, Albrecht J, Chlystun M, Jalili A, Hetman M (2003) Role of N-methyl-D-aspartate receptors in the neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin. J Biol Chem 278:43663–43671

    Article  CAS  PubMed  Google Scholar 

  • Grailer JJ, Haggadone MD, Sarma JV, Zetoune FS, Ward PA (2014) Induction of M2 regulatory macrophages through the beta2-adrenergic receptor with protection during endotoxemia and acute lung injury. J Innate Immun 6:607–618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grenhoff J, Svensson TH (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur J Pharmacol 233:79–84

    Article  CAS  PubMed  Google Scholar 

  • Grenhoff J, Nisell M, Ferre S, Aston-Jones G, Svensson TH (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 93:11–25

    Article  CAS  PubMed  Google Scholar 

  • Guiard BP, El Mansari M, Merali Z, Blier P (2008) Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. Int J Neuropsychopharmacol 11:625–639

    Article  CAS  PubMed  Google Scholar 

  • Haring JH, Davis JN (1985) Differential distribution of locus coeruleus projections to the hippocampal formation: anatomical and biochemical evidence. Brain Res 325:366–369

    Article  CAS  PubMed  Google Scholar 

  • Hasko G, Shanley TP, Egnaczyk G, Nemeth ZH, Salzman AL, Vizi ES, Szabo C (1998) Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br J Pharmacol 125:1297–1303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heerssen HM, Segal RA (2002) Location, location, location: a spatial view of neurotrophin signal transduction. Trends Neurosci 25:160–165

    Article  CAS  PubMed  Google Scholar 

  • Heneka MT, Galea E, Gavriluyk V, Dumitrescu-Ozimek L, Daeschner J, O’Banion MK, Weinberg G, Klockgether T, Feinstein DL (2002) Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer’s disease. J Neurosci 22:2434–2442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Henry B, Fox SH, Peggs D, Crossman AR, Brotchie JM (1999) The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson’s disease. Mov Disord 14:744–753

    Article  CAS  PubMed  Google Scholar 

  • Hetman M, Kanning K, Cavanaugh JE, Xia Z (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569–22580

    Article  CAS  PubMed  Google Scholar 

  • Hillman KL, Lei S, Doze VA, Porter JE (2009) Alpha-1A adrenergic receptor activation increases inhibitory tone in CA1 hippocampus. Epilepsy Res 84:97–109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirata H, Ladenheim B, Carlson E, Epstein C, Cadet JL (1996) Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res 714:95–103

    Article  CAS  PubMed  Google Scholar 

  • Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson’s disease. Nature 334:345–348

    Article  CAS  PubMed  Google Scholar 

  • Hotchkiss AJ, Gibb JW (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther 214:257–262

    CAS  PubMed  Google Scholar 

  • Hu H, Real E, Takamiya K, Kang MG, Ledoux J, Huganir RL, Malinow R (2007) Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 131:160–173

    Article  CAS  PubMed  Google Scholar 

  • Huang YY, Peng CH, Yang YP et al (2007) Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci 104:61–72

    Article  CAS  PubMed  Google Scholar 

  • Huang YZ, Pan E, Xiong ZQ, McNamara JO (2008) Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 57:546–558

    Article  CAS  PubMed  Google Scholar 

  • Inoue S, Susukida M, Ikeda K, Murase K, Hayashi K (1997) Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture. Biochem Biophys Res Commun 238:468–472

    Article  CAS  PubMed  Google Scholar 

  • Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, Classen J, Cavallari P (2011) Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol 11:88

    Article  PubMed  PubMed Central  Google Scholar 

  • Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA (2003) Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75:81–88

    Article  CAS  PubMed  Google Scholar 

  • Jhang KA, Lee EO, Kim HS, Chong YH (2014) Norepinephrine provides short-term neuroprotection against Abeta1-42 by reducing oxidative stress independent of Nrf2 activation. Neurobiol Aging 35:2465–2473

    Article  CAS  PubMed  Google Scholar 

  • Jhaveri DJ, Mackay EW, Hamlin AS, Marathe SV, Nandam LS, Vaidya VA, Bartlett PF (2010) Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors. J Neurosci 30:2795–2806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jones LS, Gauger LL, Davis JN (1985) Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat. J Comp Neurol 231:190–208

    Article  CAS  PubMed  Google Scholar 

  • Jones KR, Farinas I, Backus C, Reichardt LF (1994) Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76:989–999

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Juric DM, Miklic S, Carman-Krzan M (2006) Monoaminergic neuronal activity up-regulates BDNF synthesis in cultured neonatal rat astrocytes. Brain Res 1108:54–62

    Article  CAS  PubMed  Google Scholar 

  • Juric DM, Loncar D, Carman-Krzan M (2008) Noradrenergic stimulation of BDNF synthesis in astrocytes: mediation via alpha1- and beta1/beta2-adrenergic receptors. Neurochem Int 52:297–306

    Article  CAS  PubMed  Google Scholar 

  • Kajitani N, Hisaoka-Nakashima K, Morioka N, Okada-Tsuchioka M, Kaneko M, Kasai M, Shibasaki C, Nakata Y, Takebayashi M (2012) Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenaline. PLoS One 7:e51197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kalashnikova EV, Dymshits G, Kolpakov FA (2006) Signal transduction pathways involved in transcriptional regulation of tyrosine hydroxylase. In: Fight International Conference on Bioinformatics of Genome Regulation and Structure-BGRS’2006, pp. 128–131. Novosibirsk

  • Kalinin S, Feinstein DL, Xu HL, Huesa G, Pelligrino DA, Galea E (2006) Degeneration of noradrenergic fibres from the locus coeruleus causes tight-junction disorganisation in the rat brain. Eur J Neurosci 24:3393–3400

    Article  PubMed  Google Scholar 

  • Kang YC, Kim PK, Choi BM, Chung HT, Ha KS, Kwon YG, Kim YM (2004) Regulation of programmed cell death in neuronal cells by nitric oxide. In Vivo 18:367–376

    CAS  PubMed  Google Scholar 

  • Katsuki H, Izumi Y, Zorumski CF (1997) Noradrenergic regulation of synaptic plasticity in the hippocampal CA1 region. J Neurophysiol 77:3013–3020

    Article  CAS  PubMed  Google Scholar 

  • Kilbourn MR, Sherman P, Abbott LC (1998) Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering. Synapse 30:205–210

    Article  CAS  PubMed  Google Scholar 

  • Kim KS, Lee MK, Carroll J, Joh TH (1993) Both the basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element. J Biol Chem 268:15689–15695

    Article  CAS  PubMed  Google Scholar 

  • Kreider ML, Seidler FJ, Cousins MM, Tate CA, Slotkin TA (2004) Transiently overexpressed alpha2-adrenoceptors and their control of DNA synthesis in the developing brain. Brain Res Dev Brain Res 152:233–239

    Article  CAS  PubMed  Google Scholar 

  • Kulkarni VA, Jha S, Vaidya VA (2002) Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur J Neurosci 16:2008–2012

    Article  PubMed  Google Scholar 

  • Laifenfeld D, Klein E, Ben-Shachar D (2002) Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J Neurochem 83:1054–1064

    Article  CAS  PubMed  Google Scholar 

  • Lategan AJ, Marien MR, Colpaert FC (1990) Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res 523:134–138

    Article  CAS  PubMed  Google Scholar 

  • Lategan AJ, Marien MR, Colpaert FC (1992) Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci 50:995–999

    Article  CAS  PubMed  Google Scholar 

  • Lauder JM (1993) Neurotransmitters as growth regulatory signals: role of receptors and second messengers. Trends Neurosci 16:233–240

    Article  CAS  PubMed  Google Scholar 

  • Lee FS, Chao MV (2001) Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A 98:3555–3560

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee A, Wissekerke AE, Rosin DL, Lynch KR (1998) Localization of alpha2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience 84:1085–1096

    Article  CAS  PubMed  Google Scholar 

  • Lee FS, Rajagopal R, Kim AH, Chang PC, Chao MV (2002) Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J Biol Chem 277:9096–9102

    Article  CAS  PubMed  Google Scholar 

  • Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152

    Article  CAS  PubMed  Google Scholar 

  • Lidow MS, Rakic P (1994) Unique profiles of the alpha 1-, alpha 2-, and beta-adrenergic receptors in the developing cortical plate and transient embryonic zones of the rhesus monkey. J Neurosci 14:4064–4078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lim J, Yang C, Hong SJ, Kim KS (2000) Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors. Mol Cell Biochem 212:51–60

    Article  CAS  PubMed  Google Scholar 

  • Lindholm D, Castren E, Berzaghi M, Blochl A, Thoenen H (1994) Activity-dependent and hormonal regulation of neurotrophin mRNA levels in the brain—implications for neuronal plasticity. J Neurobiol 25:1362–1372

    Article  CAS  PubMed  Google Scholar 

  • Linner L, Endersz H, Ohman D, Bengtsson F, Schalling M, Svensson TH (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther 297:540–546

    CAS  PubMed  Google Scholar 

  • Liprando LA, Miner LH, Blakely RD, Lewis DA, Sesack SR (2004) Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area. Synapse 52:233–244

    Article  CAS  PubMed  Google Scholar 

  • Liu J, Mori A (1993) Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage. Arch Biochem Biophys 302:118–127

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Formisano L, Savtchouk I, Takayasu Y, Szabo G, Zukin RS, Liu SJ (2010) A single fear-inducing stimulus induces a transcription-dependent switch in synaptic AMPAR phenotype. Nat Neurosci 13:223–231

    Article  CAS  PubMed  Google Scholar 

  • Liu X, Ye K, Weinshenker D (2015) Norepinephrine protects against amyloid-beta toxicity via TrkB. J Alzheimers Dis 44:251–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA (2002) Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson’s disease. Eur J Neurosci 15:120–132

    Article  CAS  PubMed  Google Scholar 

  • Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104–9110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Marien M, Briley M, Colpaert F (1993) Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur J Pharmacol 236:487–489

    Article  CAS  PubMed  Google Scholar 

  • Marien M, Lategan A, Colpaert F (1994) Noradrenergic control of striatal dopamine. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson’s disease. CRC Press, Boca Raton, pp 127–138

    Google Scholar 

  • Martel J, Chopin P, Colpaert F, Marien M (1998) Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/−)-idazoxan, against quinolinic acid-induced lesions of the rat striatum. Exp Neurol 154:595–601

    Article  CAS  PubMed  Google Scholar 

  • Matsumoto M, Hikosaka O (2009) Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 459:837–841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC (1991) Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson’s disease. Neuroscience 41:507–523

    Article  CAS  PubMed  Google Scholar 

  • McAllister AK, Lo DC, Katz LC (1995) Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15:791–803

    Article  CAS  PubMed  Google Scholar 

  • McAllister AK, Katz LC, Lo DC (1996) Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 17:1057–1064

    Article  CAS  PubMed  Google Scholar 

  • McAllister AK, Katz LC, Lo DC (1999) Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22:295–318

    Article  CAS  PubMed  Google Scholar 

  • Mejias-Aponte CA (2016) Specificity and impact of adrenergic projections to the midbrain dopamine system. Brain Res 1641:258–273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mejias-Aponte CA, Drouin C, Aston-Jones G (2009) Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J Neurosci 29:3613–3626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miklic S, Juric DM, Carman-Krzan M (2004) Differences in the regulation of BDNF and NGF synthesis in cultured neonatal rat astrocytes. Int J Dev Neurosci 22:119–130

    Article  CAS  PubMed  Google Scholar 

  • Mittal S, Bjornevik K, Im DS et al (2017) beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson’s disease. Science 357:891–898

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moore RY, Bloom FE (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2:113–168

    Article  CAS  PubMed  Google Scholar 

  • Morrison JH, Molliver ME, Grzanna R (1979) Noradrenergic innervation of cerebral cortex: widespread effects of local cortical lesions. Science 205:313–316

    Article  CAS  PubMed  Google Scholar 

  • Mosley RL, Hutter-Saunders JA, Stone DK, Gendelman HE (2012) Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb Perspect Med 2:a009381

    Article  PubMed  PubMed Central  Google Scholar 

  • Musazzi L, Rimland JM, Ieraci A, Racagni G, Domenici E, Popoli M (2014) Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. Int J Neuropsychopharmacol 17:779–791

    Article  CAS  PubMed  Google Scholar 

  • Nagamoto-Combs K, Piech KM, Best JA, Sun B, Tank AW (1997) Tyrosine hydroxylase gene promoter activity is regulated by both cyclic AMP-responsive element and AP1 sites following calcium influx. Evidence for cyclic amp-responsive element binding protein-independent regulation. J Biol Chem 272:6051–6058

    Article  CAS  PubMed  Google Scholar 

  • Nawa H, Pelleymounter MA, Carnahan J (1994) Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J Neurosci 14:3751–3765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Noh JS, Kim EY, Kang JS, Kim HR, Oh YJ, Gwag BJ (1999) Neurotoxic and neuroprotective actions of catecholamines in cortical neurons. Exp Neurol 159:217–224

    Article  CAS  PubMed  Google Scholar 

  • Numan S, Lane-Ladd SB, Zhang L, Lundgren KH, Russell DS, Seroogy KB, Nestler EJ (1998) Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci 18:10700–10708

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ (2009) Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol 12:687–699

    Article  PubMed  CAS  Google Scholar 

  • O’Sullivan JB, Ryan KM, Harkin A, Connor TJ (2010) Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. J Neuroimmunol 220:34–42

    Article  PubMed  CAS  Google Scholar 

  • Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117–165

    Article  CAS  PubMed  Google Scholar 

  • Orefice LL, Waterhouse EG, Partridge JG, Lalchandani RR, Vicini S, Xu B (2013) Distinct roles for somatically and dendritically synthesized brain-derived neurotrophic factor in morphogenesis of dendritic spines. J Neurosci 33:11618–11632

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patel NJ, Chen MJ, Russo-Neustadt AA (2010) Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. Eur J Pharmacol 633:1–9

    Article  CAS  PubMed  Google Scholar 

  • Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P (2005) Pathological synaptic plasticity in the striatum: implications for Parkinson’s disease. Neurotoxicology 26:779–783

    Article  CAS  PubMed  Google Scholar 

  • Popovik E, Haynes LW (2000) Survival and mitogenesis of neuroepithelial cells are influenced by noradrenergic but not cholinergic innervation in cultured embryonic rat neopallium. Brain Res 853:227–235

    Article  CAS  PubMed  Google Scholar 

  • Rajagopal R, Chen ZY, Lee FS, Chao MV (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24:6650–6658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rascol O, Arnulf I, Peyro-Saint Paul H et al (2001) Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson’s disease. Mov Disord 16:708–713

    Article  CAS  PubMed  Google Scholar 

  • Reichardt LF (2006) Neurotrophin-regulated signalling pathways. Philos Trans R Soc London Ser B Biol Sci 361:1545–1564

    Article  CAS  Google Scholar 

  • Robbins TW (2000) From arousal to cognition: the integrative position of the prefrontal cortex. Prog Brain Res 126:469–483

    Article  CAS  PubMed  Google Scholar 

  • Robbins T, Everitt B (1995) Central norepinephrine neurons and behavior. In: Bloom F, Kupfer D (eds) Neuropsychopharmacology: the fourth generation of progress. Raven Press, New York

    Google Scholar 

  • Rommelfanger KS, Weinshenker D, Miller GW (2004) Reduced MPTP toxicity in noradrenaline transporter knockout mice. J Neurochem 91:1116–1124

    Article  CAS  PubMed  Google Scholar 

  • Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci U S A 104:13804–13809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ross RA, Reis DJ (1974) Effects of lesions of locus coeruleus on regional distribution of dopamine-beta-hydroxylase activity in rat brain. Brain Res 73:161–166

    Article  CAS  PubMed  Google Scholar 

  • Ruiz CR, Shi J, Meffert MK (2014) Transcript specificity in BDNF-regulated protein synthesis. Neuropharmacology 76(Pt C):657–663

    Article  CAS  PubMed  Google Scholar 

  • Samuels ER, Szabadi E (2008) Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 6:235–253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223

    Article  CAS  PubMed  Google Scholar 

  • Satoh T, Nakai S, Sato T, Kimura M (2003) Correlated coding of motivation and outcome of decision by dopamine neurons. J Neurosci 23:9913–9923

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD (2000) Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol 420:211–232

    Article  CAS  PubMed  Google Scholar 

  • Schwartz JP, Nishiyama N (1994) Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res Bull 35:403–407

    Article  CAS  PubMed  Google Scholar 

  • Schwartz JP, Nishiyama N, Wilson D, Taniwaki T (1994) Receptor-mediated regulation of neuropeptide gene expression in astrocytes. Glia 11:185–190

    Article  CAS  PubMed  Google Scholar 

  • Sciarretta C, Fritzsch B, Beisel K, Rocha-Sanchez SM, Buniello A, Horn JM, Minichiello L (2010) PLCgamma-activated signalling is essential for TrkB mediated sensory neuron structural plasticity. BMC Dev Biol 10:103

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Segal M, Bloom FE (1976) The action of norepinephrine in the rat hippocampus. III. Hippocampal cellular responses to locus coeruleus stimulation in the awake rat. Brain Res 107:499–511

    Article  CAS  PubMed  Google Scholar 

  • Segal RA (2003) Selectivity in neurotrophin signaling: theme and variations. Annu Rev Neurosci 26:299–330

    Article  CAS  PubMed  Google Scholar 

  • Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821–861

    Article  CAS  PubMed  Google Scholar 

  • Shepard KN, Liles LC, Weinshenker D, Liu RC (2015) Norepinephrine is necessary for experience-dependent plasticity in the developing mouse auditory cortex. J Neurosci 35:2432–2437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Siciliano R, Fornai F, Bonaccorsi I, Domenici L, Bagnoli P (1999) Cholinergic and noradrenergic afferents influence the functional properties of the postnatal visual cortex in rats. Vis Neurosci 16:1015–1028

    Article  CAS  PubMed  Google Scholar 

  • Simon H, Le Moal M, Stinus L, Calas A (1979) Anatomical relationships between the ventral mesencephalic tegmentum—a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm 44:77–86

    Article  CAS  PubMed  Google Scholar 

  • Smith MA, Makino S, Altemus M, Michelson D, Hong SK, Kvetnansky R, Post RM (1995) Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleus. Proc Natl Acad Sci U S A 92:8788–8792

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL (1994) Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 152:3024–3031

    CAS  PubMed  Google Scholar 

  • Srinivasan J, Schmidt WJ (2003) Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Eur J Neurosci 17:2586–2592

    Article  CAS  PubMed  Google Scholar 

  • Sterpenich V, D’Argembeau A, Desseilles M et al (2006) The locus ceruleus is involved in the successful retrieval of emotional memories in humans. J Neurosci 26:7416–7423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stroemer RP, Kent TA, Hulsebosch CE (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 29:2381–2393 discussion 2393-2385

    Article  CAS  PubMed  Google Scholar 

  • Sullivan RM, Wilson DA, Leon M (1989) Norepinephrine and learning-induced plasticity in infant rat olfactory system. J Neurosci 9:3998–4006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sullivan RM, McGaugh JL, Leon M (1991) Norepinephrine-induced plasticity and one-trial olfactory learning in neonatal rats. Brain Res Dev Brain Res 60:219–228

    Article  CAS  PubMed  Google Scholar 

  • Suzuki T, Kurahashi H, Ichinose H (2004) Ras/MEK pathway is required for NGF-induced expression of tyrosine hydroxylase gene. Biochem Biophys Res Commun 315:389–396

    Article  CAS  PubMed  Google Scholar 

  • Swanson LW (1982) The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9:321–353

    Article  CAS  PubMed  Google Scholar 

  • Swanson LW, Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163:467–505

    Article  CAS  PubMed  Google Scholar 

  • Szabo C, Hasko G, Zingarelli B, Nemeth ZH, Salzman AL, Kvetan V, Pastores SM, Vizi ES (1997) Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology 90:95–100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takahashi M, Niki E (1998) The effect of oxidative stress on cells by oxygen radicals and its inhibition by antioxidants. In: Montagnier L, Olivier R, Pasquier F (eds) Oxidative stress in cancer, AIDA and neurodegenerative diseases. Marcel Decker, New York, pp 9–14

    Google Scholar 

  • Thastrup O, Knudsen JB, Lemmich J, Winther K (1985) Inhibition of human platelet aggregation by dihydropyrano- and dihydrofuranocoumarins, a new class of cAMP-phosphodiesterase inhibitors. Biochem Pharmacol 34:2137–2140

    Article  CAS  PubMed  Google Scholar 

  • Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593–598

    Article  CAS  PubMed  Google Scholar 

  • Timmer M, Cesnulevicius K, Winkler C, Kolb J, Lipokatic-Takacs E, Jungnickel J, Grothe C (2007) Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J Neurosci 27:459–471

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tinti C, Conti B, Cubells JF, Kim KS, Baker H, Joh TH (1996) Inducible cAMP early repressor can modulate tyrosine hydroxylase gene expression after stimulation of cAMP synthesis. J Biol Chem 271:25375–25381

    Article  CAS  PubMed  Google Scholar 

  • Tong J, Hornykiewicz O, Kish SJ (2006) Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Arch Neurol 63:1724–1728

    Article  PubMed  Google Scholar 

  • Traver S, Salthun-Lassalle B, Marien M, Hirsch EC, Colpaert F, Michel PP (2005) The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol 67:1882–1891

    Article  CAS  PubMed  Google Scholar 

  • Troadec JD, Marien M, Darios F, Hartmann A, Ruberg M, Colpaert F, Michel PP (2001) Noradrenaline provides long-term protection to dopaminergic neurons by reducing oxidative stress. J Neurochem 79:200–210

    Article  CAS  PubMed  Google Scholar 

  • Troadec JD, Marien M, Mourlevat S, Debeir T, Ruberg M, Colpaert F, Michel PP (2002) Activation of the mitogen-activated protein kinase (ERK(1/2)) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol Pharmacol 62:1043–1052

    Article  CAS  PubMed  Google Scholar 

  • Vauquelin G, Geynet P, Hanoune J, Strosberg AD (1979) Affinity chromatography of the beta-adrenergic receptor from Turkey erythrocytes. Eur J Biochem 98:543–556

    Article  CAS  PubMed  Google Scholar 

  • Vijayashankar N, Brody H (1979) A quantitative study of the pigmented neurons in the nuclei locus coeruleus and subcoeruleus in man as related to aging. J Neuropathol Exp Neurol 38:490–497

    Article  CAS  PubMed  Google Scholar 

  • Vitalis T, Cases O, Parnavelas JG (2005) Development of the dopaminergic neurons in the rodent brainstem. Exp Neurol 191(Suppl 1):S104–S112

    Article  CAS  PubMed  Google Scholar 

  • Vizi ES, Orso E, Osipenko ON, Hasko G, Elenkov IJ (1995) Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68:1263–1276

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Zhang QJ, Liu J, Ali U, Gui ZH, Hui YP, Chen L, Wu ZH, Li Q (2010) Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson’s disease. Brain Res 1310:189–199

    Article  CAS  PubMed  Google Scholar 

  • Weinshenker D, Ferrucci M, Busceti CL et al (2008) Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine. J Neurochem 105:471–483

    Article  CAS  PubMed  Google Scholar 

  • Widmer HR, Kaplan DR, Rabin SJ, Beck KD, Hefti F, Knusel B (1993) Rapid phosphorylation of phospholipase C gamma 1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons. J Neurochem 60:2111–2123

    Article  CAS  PubMed  Google Scholar 

  • Xing B, Xin T, Zhao L, Hunter RL, Chen Y, Bing G (2010) Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity. J Neuroimmunol 225:43–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yamada M, Ohnishi H, Sano S, Araki T, Nakatani A, Ikeuchi T, Hatanaka H (1999) Brain-derived neurotrophic factor stimulates interactions of Shp2 with phosphatidylinositol 3-kinase and Grb2 in cultured cerebral cortical neurons. J Neurochem 73:41–49

    Article  CAS  PubMed  Google Scholar 

  • Yanpallewar SU, Fernandes K, Marathe SV et al (2010) Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. J Neurosci 30:1096–1109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yuan J, Yankner BA (2000) Apoptosis in the nervous system. Nature 407:802–809

    Article  CAS  PubMed  Google Scholar 

  • Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H (1992) Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 12:4793–4799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341

    Article  PubMed  Google Scholar 

  • Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311–322

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA

    Meng-Yang Zhu

Authors
  1. Meng-Yang Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meng-Yang Zhu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, MY. Noradrenergic Modulation on Dopaminergic Neurons. Neurotox Res 34, 848–859 (2018). https://doi.org/10.1007/s12640-018-9889-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-018-9889-z

Keywords

Search

Navigation